Clinical Trial Update: Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver [NA]

View source ↗

Summary

A clinical trial evaluating acenocoumarol for portal vein thrombosis in liver cirrhosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Vein Thrombosis

Drugs mentioned

• Acenocoumarol (Acenocoumarol)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Portal Vein Thrombosis | NA | Status: WITHDRAWN